Eduard Ayuso, a highly accomplished professional with over 20 years of experience in gene therapy, is currently serving as the Chief Technology Officer at DiNAQOR AG. With a Doctorate in Veterinary Medicine and a PhD in Biochemistry and Molecular Biology from the Autonomous University of Barcelona, Ayuso has held various prestigious positions throughout his career, including Vice-President at Société Française de Thérapie Cellulaire et Génique, and as an INSERM Researcher and Head of Innovative Vectorology at the University of Nantes.

Considered an expert in the field of vectorology, translational medicine, and viral vector manufacturing, Ayuso has published over 50 research articles in international journals. He has served as the scientific director of the Translational Vector Core at the University of Nantes and has also worked as a Visiting Research Scientist at ICGEB, a Visiting PHD Student at Universität Ulm and a Staff Researcher at Universitat Autònoma de Barcelona.

Ayuso's extensive background in gene therapy and related fields makes him a valuable asset to any organization looking to make strides in the field. In this domain, he has earned himself a reputation as a highly accomplished researcher and a thought leader.